FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 623
Summary
- Conditions
- Ventricular Tachycardia
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Pivotal medical device studyMasking: Single (Participant)Masking Description: Subjects are blinded to the randomization assignment.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03490201
- Collaborators
- Not Provided
- Investigators
- Study Director: Kristin Ruffner, PhD Abbott
Get Well Soon